Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tissue Regeneration Therapeutics

Tissue Regeneration Therapeutics?uq=PEM9b6PF
2004 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
PE Growth LATEST DEAL TYPE
4 FINANCING ROUNDS
Description

Operator of a biotechnology company focused on the development of human umbilical cord perivascular cells (HUCPVC) platform and other cell therapy products. The company's cell products, which include mesenchymal stem cells (MSCs) have regenerative, angiogenic, anti-inflammatory and immunoregulatory properties, enabling clinical-scientific groups to use it in their pre-clinical research for a variety of indications.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Primary Office
  • 790 Bay Street, Suite 512
  • Post Box 55
  • Toronto, Ontario M5G 1N8
  • Canada

+1 (416) 000-0000

Tissue Regeneration Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Tissue Regeneration Therapeutics‘s full profile, request access.

Request full access to PitchBook

Tissue Regeneration Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Tissue Regeneration Therapeutics‘s full profile, request access.

Request full access to PitchBook

Tissue Regeneration Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
John Davies Ph.D President & Chief Executive Officer
Bruce Berckmans Vice President, Business Development

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »